Alia Therapeutics

Where the EU money came from

Funding by EU programme. Amounts are Alia Therapeutics's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• IMMERGEAssociated partner

  Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €144ktheir share
• GET-INAssociated partner

  The GEne Therapy INnovation Training Network

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €180ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Universita Degli Studi di TrentoItaly · 2 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• Katholieke Universiteit LeuvenBelgium · 1 shared project
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• The Hebrew University of JerusalemIsrael · 1 shared project
• Universiteit LeidenNetherlands · 1 shared project
• European Molecular Biology LaboratoryGermany · 1 shared project
• Eberhard Karls Universitaet TuebingenGermany · 1 shared project
• Aristotelio Panepistimio ThessalonikisGreece · 1 shared project
• Universidad Pompeu FabraSpain · 1 shared project
• Universitat de BarcelonaSpain · 1 shared project
• Albert-Ludwigs-Universitaet FreiburgGermany · 1 shared project
• Universitat BaselSwitzerland · 1 shared project
• Universite D'Aix MarseilleFrance · 1 shared project
• Universitaetsklinikum FreiburgGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• cell signaling
• gene therapy
• immunology
• mutation
• oncology